Skip to content

Author

M. Lanza

We have 2 of 126 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

RIPK1 in Alzheimer’s Disease: A Context-Dependent Signaling Hub Linking Aβ, Tau, Neuroinflammation, and Regulated Cell Death

Alzheimer’s disease is a multifactorial neurodegenerative disorder in which amyloid-β accumulation, tau pathology, neuroinflammation, synaptic dysfunction, vascular injury, and neuronal loss interact across multiple cellular compartments. Although amyloid and tau remain central to disease definition and biomarker stagi...

Antonella Caccamo, M. Lanza, G. Casili et al. · 0 citations
Open access Jan 2026

Tempol Ameliorates Psoriatic Skin Inflammation: Evidence of TLR4/NF‐κB/Nrf2 Axis Modulation

Psoriasis is a chronic inflammatory skin disorder characterized by keratinocyte hyperproliferation, immune dysregulation, oxidative stress, and impaired epidermal barrier function. In the present study, we investigated the protective effects of Tempol, a membrane‐permeable nitroxide with antioxidant and anti‐inflammato...

S. Scuderi, M. Lanza, A. Capra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.